Cytokinetics Executive Sells Stock Amid Positive Drug Developments
Executive Stock Activities at Cytokinetics Malik Fady Ibraham, the Executive Vice President of Research & Development at Cytokinetics, Inc. (NASDAQ: CYTK), has been actively trading shares of the company. Recent filings with the SEC show that he made both purchases and sales of Cytokinetics stock on a notable trading day, demonstrating his engagement in the company’s...
Continue Reading